Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

PW Medtech Group Limited (PWE.F)

Compare
0.0930
-0.0040
(-4.12%)
At close: April 10 at 8:06:17 AM GMT+2
Loading Chart for PWE.F
  • Previous Close 0.0970
  • Open 0.0930
  • Bid 0.0990 x --
  • Ask 0.1300 x --
  • Day's Range 0.0930 - 0.0930
  • 52 Week Range 0.0920 - 0.1440
  • Volume 1,070
  • Avg. Volume 400
  • Market Cap (intraday) 163.74M
  • Beta (5Y Monthly) 0.62
  • PE Ratio (TTM) 9.30
  • EPS (TTM) 0.0100
  • Earnings Date Mar 28, 2025
  • Forward Dividend & Yield 0.01 (10.95%)
  • Ex-Dividend Date Jul 3, 2025
  • 1y Target Est --

PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, North America, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical devices; high flux hemodialyzers, low flux hemodialyzers, hemodiafilters, and hemoperfutors; and animal-derived regenerative medical biomaterials and human tissue repair alternative products. The company was formerly known as Pyholding Limited. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

www.pwmedtech.com

1,415

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PWE.F

View More

Performance Overview: PWE.F

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

PWE.F
13.89%
HANG SENG INDEX (^HSI)
4.06%

1-Year Return

PWE.F
135.10%
HANG SENG INDEX (^HSI)
22.11%

3-Year Return

PWE.F
588.39%
HANG SENG INDEX (^HSI)
1.58%

5-Year Return

PWE.F
103.03%
HANG SENG INDEX (^HSI)
14.10%

Compare To: PWE.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PWE.F

View More

Valuation Measures

Annual
As of 4/10/2025
  • Market Cap

    173.18M

  • Enterprise Value

    -34.94M

  • Trailing P/E

    7.66

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.50

  • Price/Book (mrq)

    0.28

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.61%

  • Return on Assets (ttm)

    2.11%

  • Return on Equity (ttm)

    4.00%

  • Revenue (ttm)

    768.9M

  • Net Income Avi to Common (ttm)

    150.78M

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.69B

  • Total Debt/Equity (mrq)

    0.25%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: PWE.F

View More

Company Insights: PWE.F

Research Reports: PWE.F

View More

People Also Watch